Compare MSTR & IDXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MSTR | IDXX |
|---|---|---|
| Founded | 1989 | 1983 |
| Country | United States | United States |
| Employees | N/A | 11000 |
| Industry | Computer Software: Prepackaged Software | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.6B | 43.6B |
| IPO Year | 1998 | 1996 |
| Metric | MSTR | IDXX |
|---|---|---|
| Price | $159.79 | $558.59 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 9 |
| Target Price | $343.77 | ★ $721.67 |
| AVG Volume (30 Days) | ★ 11.4M | 578.8K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 22.59 |
| EPS | N/A | ★ 3.47 |
| Revenue | $463,456,000.00 | ★ $4,303,702,000.00 |
| Revenue This Year | $5.22 | $10.88 |
| Revenue Next Year | $2.41 | $8.59 |
| P/E Ratio | ★ N/A | $159.66 |
| Revenue Growth | N/A | ★ 10.42 |
| 52 Week Low | $105.00 | $504.56 |
| 52 Week High | $457.22 | $769.98 |
| Indicator | MSTR | IDXX |
|---|---|---|
| Relative Strength Index (RSI) | 44.71 | 50.01 |
| Support Level | $154.37 | $554.61 |
| Resistance Level | $192.21 | $595.15 |
| Average True Range (ATR) | 9.20 | 19.51 |
| MACD | -4.03 | 1.96 |
| Stochastic Oscillator | 1.65 | 55.62 |
Strategy Inc is a bitcoin treasury company and a provider of business intelligence services. It is designed to provide investors varying degrees of economic exposure to Bitcoin by offering a range of securities, including equity and fixed-income instruments. The company also provides industry AI-powered enterprise analytics software. It has one reportable operating segment: the Software Business, which is engaged in the design, development, marketing, and sales of the company's enterprise analytics software platform through cloud subscriptions and licensing arrangements and related services (i.e., product support, consulting, and education). Geographically, the company operates in EMEA, U.S. and Other Regions, of which maximum revenue is derived from U.S..
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.